Metabolic syndrome as a risk factor for neurological disorders (original) (raw)

• Flegal KM, Carroll MD, Ogden CL, Curtin R (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–241
  Article PubMed CAS Google Scholar
• Reaven GM, Laws A (1999) Insulin resistance: the metabolic syndrome X. Humana Press Totowa, NJ
  Google Scholar
• Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA, American Heart Association (2004) Clinical management of metabolic syndrome report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109:551–556
  Article PubMed Google Scholar
• Groenendijk M, Cantor RM, Blom NH, Rotter JI, de Bruin TW, Dallinga-Thie GM (1999) Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia. J Lipid Res 40:1036–1044
  PubMed CAS Google Scholar
• Mooradian AD, Haas MJ, Wong NC (2004) Transcriptional control of apolipoprotein A-I gene expression in diabetes. Diabetes 53:513–520
  Article PubMed CAS Google Scholar
• Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, Dandona P (2003) Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52(12):2882–2887
  Article PubMed CAS Google Scholar
• Roden M, Perseghin G, Petersen KF, Hwang JH, Cline GW, Gerow K, Rothman DL, Shulman GI (1996) The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 97:642–648
  Article PubMed CAS Google Scholar
• Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176
  Article PubMed CAS Google Scholar
• Greenberg AS, Obin MS (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83:S461–S465
  Google Scholar
• Ahima RS, Osei SY (2008) Adipokines in obesity. Front Horm Res 36:182–197
  Article PubMed CAS Google Scholar
• Uranga RM, Bruce-Keller AJ, Morrison CD, Fernandez-Kim SO, Ebenezer PJ, Zhang L, Dasuri K, Keller JN (2010) Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. J Neurochem 114:344–361
  Article PubMed CAS Google Scholar
• Moller DE, Kaufman KD (2005) Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56:45–62
  Article PubMed CAS Google Scholar
• Wang S, Ma A, Song S, Quan Q, Zhao X, Zheng X (2008) Fasting serum free fatty acid composition, waist/hip ratio and insulin activity in essential hypertensive patients. Hypertens Res 31:623–632
  Article PubMed Google Scholar
• Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880
  Article PubMed CAS Google Scholar
• Lteif AA, Han K, Mather KJ (2005) Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation 112:32–38
  Article PubMed CAS Google Scholar
• Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97:2601–2610
  Article PubMed CAS Google Scholar
• Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr, Wilson PW (2004) C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110:380–385
  Article PubMed CAS Google Scholar
• Aizawa Y, Watanabe H, Ramadan MM, Usuda Y, Watanabe T, Sasaki S (2007) Clustering trend of components of metabolic syndrome. Int J Cardiol 121:117–118
  Article PubMed Google Scholar
• Dhindsa S, Tripathy D, Mohanty P, Ghanim H, Syed T, Aljada A, Dandona P (2004) Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factorkappaB in mononuclear cells. Metabolism 53:330–334
  Article PubMed CAS Google Scholar
• Yu YH, Ginsberg HN (2005) Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 96:1042–1052
  Article PubMed CAS Google Scholar
• Friedman JM (2004) Modern science versus the stigma of obesity. Nat Med 10:563–569
  Article PubMed CAS Google Scholar
• Trayhurn P, Hoggard N, Mercer JG, Rayner DV (1999) Leptin: fundamental aspects. Int J Obes Relat Metab Disord 23(Suppl 1):22–28
  Article PubMed CAS Google Scholar
• Shimabukuro M, Koyama K, Chen G, Wang M-Y, Trieu F, Lee Y, Newgard CB, Unger RH (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94:4637–4641
  Article PubMed CAS Google Scholar
• Flier JS (1998) What’s in a name? In search of leptin’s physiologic role. J Clin Endocrinol Metab 83:1407–1413
  Article PubMed CAS Google Scholar
• Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND (2006) Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in dietinduced metabolic syndrome. Metabolism 55:928–934
  Article PubMed CAS Google Scholar
• Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L (2010) Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 6:71–82
  Article PubMed CAS Google Scholar
• Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F (2010) Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer’s disease. Ageing Res Rev 9:399–417
  Article PubMed Google Scholar
• Oxenkrug GF (2010) Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann N Y Acad Sci 1199:1–14
  Article PubMed CAS Google Scholar
• Luchsinger JA, Gustafson DR (2009) Adiposity, type 2 diabetes, and Alzheimer’s disease. J Alzheimers Dis 16:693–704
  PubMed Google Scholar
• Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, Pilotto A, Panza F (2010) Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis 21:57–63
  PubMed CAS Google Scholar
• Delzenne NM, Cani PD, Neyrinck AM (2007) Modulation of glucagon-like peptide1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr 137(11 Suppl):2547S–2551S
  PubMed CAS Google Scholar
• Burcelin R, Cani PD, Knauf C (2007) Glucagon-like peptide-1 and energy homeostasis. J Nutr 137(11 Suppl):2534S–2538S
  PubMed CAS Google Scholar
• Flier JS (2004) Obesity wars: molecular progress confronts an expanding epidemic. Cell 116:337–350
  Article PubMed CAS Google Scholar
• Seeley RJ, York DA (2005) Fuel sensing and the central nervous system (CNS): implications for the regulation of energy balance and the treatment for obesity. Obes Rev 6:259–265
  Article PubMed CAS Google Scholar
• Strader AD, Woods SC (2005) Gastrointestinal hormones and food intake. Gastroenterology 128(1):175–191
  Article PubMed CAS Google Scholar
• Perez-Tilve D, Stern JE, Tschöp M (2006) The brain and the metabolic syndrome: not a wireless connection. Endocrinology 147:1136–1139
  Article PubMed CAS Google Scholar
• Zsombok A, Smith BN (2009) Plasticity of central autonomic neural circuits in diabetes. Biochim Biophys Acta 1792:423–431
  PubMed CAS Google Scholar
• Pocai A, Obici S, Schwartz GJ, Rossetti L (2005) A brain-liver circuit regulates glucose homeostasis. Cell Metab 1:53–61
  Article PubMed CAS Google Scholar
• Song CK, Jackson RM, Harris RB, Richard D, Bartness TJ (2005) Melanocortin- 4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue. Am J Physiol Regul Integr Comp Physiol 289:R1467–R1476
  Article PubMed CAS Google Scholar
• Penicaud L, Leloup C, Fioramonti X, Lorsignol A, Benani A (2006) Brain glucose sensing: a subtle mechanism. Curr Opin Clin Nutr Metab Care 9:458–462
  Article PubMed CAS Google Scholar
• Lam TK, Schwartz GJ, Rossetti L (2005) Hypothalamic sensing of fatty acids. Nat Neurosci 8(5):579–584
  Article PubMed CAS Google Scholar
• Niijima A (1985) Blood glucose levels modulate efferent activity in the vagal supply to the rat liver. J Physiol 364:105–112
  PubMed CAS Google Scholar
• Shimazu T, Fukuda A, Ban T (1966) Reciprocal influences of the ventromedial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content. Nature 210:1178–1179
  Article PubMed CAS Google Scholar
• Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, Rossetti L (2005) Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434:1026–1031
  Article PubMed CAS Google Scholar
• Hill JM, Lesniak MA, Pert CB, Roth J (1986) Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 17:1127–1138
  Article PubMed CAS Google Scholar
• de la Monte SM, Wands JR (2008) Alzheimer’s disease is type 3 diabetes—evidence reviewed. J Diabetes Sci Technol 2:1101–1113
  Google Scholar
• Freude S, Leeser U, Muller M, Hettich MM, Udelhoven M, Schilbach K, Tobe K, Kadowaki T, Kohler C, Schroder H, Krone W, Bruning JC, Schubert M (2008) IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination. J Neurochem 107:907–917
  PubMed CAS Google Scholar
• D’Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G (1996) The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13:227–255
  Article PubMed Google Scholar
• Martin DE, Hall MN (2005) The expanding TOR signaling network. Curr Opin Cell Biol 17(2):158–166
  Article PubMed CAS Google Scholar
• Rui L (2007) A link between protein translation and body weight. J Clin Invest 117:310–313
  Article PubMed CAS Google Scholar
• Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, Hall MN (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6:1122–1128
  Article PubMed CAS Google Scholar
• Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N, Leibowitz G (2008) mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57:945–957
  Article PubMed CAS Google Scholar
• Baskin DG, Figlewicz Lattermann D, Seeley RJ, Woods SC, Porte D Jr, Schwartz MW (1999) Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res 848:114–123
  Article PubMed CAS Google Scholar
• Hadari YR, Tzahar E, Nadiv O, Rothenberg P, Roberts CT Jr, LeRoith D, Yarden Y, Zick Y (1992) Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3′-kinase upon its association with pp185 (IRS-1) in intact rat livers. J Biol Chem 267:17483–17486
  PubMed CAS Google Scholar
• Tartaglia LA (1997) The leptin receptor. J Biol Chem 272:6093–6096
  PubMed CAS Google Scholar
• Koch CA, Anderson D, Moran MF, Ellis C, Pawson T (1991) SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252:668–674
  Article PubMed CAS Google Scholar
• Davis JF, Choi DL, Benoit SC (2010) Insulin, leptin and reward. Trends Endocrinol Metab 21:68–74
  Article PubMed CAS Google Scholar
• Myers MG Jr (2004) Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res 59:287–304
  Article PubMed CAS Google Scholar
• Xu AW, Kaelin CB, Takeda K, Akira S, Schwartz MW, Barsh GS (2005) PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest 115:951–958
  PubMed CAS Google Scholar
• Morrison CD, Morton GJ, Niswender KD, Gelling RW, Schwartz MW (2005) Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. Am J Physiol Endocrinol Metab 289:E1051–E1057
  Article PubMed CAS Google Scholar
• Mirshamsi S, Laidlaw HA, Ning K, Anderson E, Burgess LA, Gray A, Sutherland C, Ashford ML (2004) Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: PI3K dependent actin reorganization and KATP channel activation. BMC Neurosci 5:54
  Article PubMed CAS Google Scholar
• Kim MS, Pak YK, Jang PG, Namkoong C, Choi YS, Won JC, Kim KS, Kim SW, Kim HS, Park JY, Kim YB, Lee KU (2006) Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat Neurosci 9:901–906
  Article PubMed CAS Google Scholar
• Morton GJ, Blevins JE, Kim F, Matsen M, Figlewicz DP (2009) The action of leptin in the ventral tegmental area to decrease food intake is dependent on Jak-2 signaling. Am J Physiol Endocrinol Metab 297:E202–E210
  Article PubMed CAS Google Scholar
• Farooqui AA (2011) Lipid mediators and their metabolism in the brain. Springer, New York
  Book Google Scholar
• Riccardi G, Giacco R, Rivellese AA (2004) Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23:447–456
  Article PubMed CAS Google Scholar
• Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS (1987) Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237:885–888
  Article PubMed CAS Google Scholar
• Glauser DA, Schlegel W (2007) The emerging role of FOXO transcription factors in pancreatic beta cells. J Endocrinol 193:195–207
  Article PubMed CAS Google Scholar
• Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH 3rd, Wright CV, White MF, Arden KC, Accili D (2002) The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110:1839–1847
  PubMed CAS Google Scholar
• Szanto I, Kahn CR (2000) Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci USA 97:2355–2360
  Article PubMed CAS Google Scholar
• Portois L, Hacquebard M, Malaisse WJ, Carpentier YA (2009) The metabolic syndrome of omega3-depleted rats. III. Brain phospholipids. Int J Mol Med 24:269–278
  PubMed CAS Google Scholar
• Edidin M (2003) The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 32:257–283
  Article PubMed CAS Google Scholar
• Yaqoob P, Shaikh SR (2010) The nutritional and clinical significance of lipid rafts. Curr Opin Clin Nutr Metab Care 13:156–166
  Article PubMed CAS Google Scholar
• Plata-Salaman CR (1991) Insulin in the cerebrospinal fluid. Neurosci Biobehav Rev 15:243–258
  Article PubMed CAS Google Scholar
• Unger J, McNeill TH, Moxley RT, White M, Moss A, Livingston JN (1989) Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 31:143–157
  Article PubMed CAS Google Scholar
• de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease. J Alzheimers Dis 7:45–61
  PubMed Google Scholar
• Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, Pilotto A, Solfrizzi V (2010) Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. J Alzheimers Dis 22:715–740
  PubMed CAS Google Scholar
• Farooqui AA (2009) Effect of fish oil on human brain. Springer, New York
  Book Google Scholar
• Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88:4673–4676
  Article PubMed CAS Google Scholar
• Haffner SM (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97:3A–11A
  Article PubMed CAS Google Scholar
• Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599–622
  Article PubMed CAS Google Scholar
• Muoio DM, Newgard CB (2006) Obesity-related derangements in metabolic regulation. Annu Rev Biochem 75:367–401
  Article PubMed CAS Google Scholar
• Dimopoulos N, Watson M, Sakamoto K, Hundal HS (2006) Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J 399:473–481
  Article PubMed CAS Google Scholar
• Hajduch E, Litherland GJ, Hundal HS (2001) Protein kinase B: a key regulator of glucose transport? FEBS Lett 492:199–203
  Article PubMed CAS Google Scholar
• Merrill AH Jr (2002) De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 277:25843–25846
  Article PubMed CAS Google Scholar
• Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, Nelson DH, Karathanasis SK, Fontenot GK, Birnbaum MJ, Summers SA (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 593:167–179
  Article CAS Google Scholar
• Opara EC, Garfinkel M, Hubbard VS, Burch WM, Akwari OE (1994) Effect of fatty acids on insulin release: role of chain length and degree of unsaturation. Am J Physiol 266(4 Pt 1):E635–E639
  PubMed CAS Google Scholar
• Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willett WC (2001) Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73:1019–1026
  PubMed CAS Google Scholar
• Fedor D, Kelley DS (2009) Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 12:138–146
  Article PubMed CAS Google Scholar
• Pérez-Matute P, Marti A, Martínez JA, Fernández-Otero MP, Stanhope KL, Havel PJ, Moreno-Aliaga MJ (2005) Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism. Am J Physiol Regul Integr Comp Physiol 288:R1682–R1688
  Article PubMed CAS Google Scholar
• Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N (2010) Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 140:1915–1922
  Article PubMed CAS Google Scholar
• Kraveka JM, Li L, Szulc ZM, Bielawski J, Ogretmen B, Hannun YA, Obeid LM, Bielawska A (2007) Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J Biol Chem 282:16718–16728
  Article PubMed CAS Google Scholar
• Hu W, Ross JS, Geng T, Brice SE, Cowart LA (2011) Differential regulation of dihydroceramide desaturase by palmitate vs. monounsaturated fatty acids: implications to insulin resistance. J Biol Chem 285:35792–35802
  Google Scholar
• Shmueli E, Alberti KG, Record CO (1993) Diacylglycerol/ protein kinase C signalling: a mechanism for insulin resistance? J Intern Med 234:397–400
  Article PubMed CAS Google Scholar
• Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005–2011
  Article PubMed CAS Google Scholar
• Montell E, Turini M, Marotta M, Roberts M, Noé V, Ciudad CJ, Macé K, Gómez-Foix AM (2001) DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol Endocrinol Metab 280:E229–E237
  PubMed CAS Google Scholar
• Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, McGarry JD (2001) Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50:123–130
  Article PubMed CAS Google Scholar
• Schmitz-Peiffer C (2010) Targeting ceramide synthesis to reverse insulin resistance. Diabetes 59:2351–2353
  Article PubMed CAS Google Scholar
• Tada N (2004) Physiological actions of diacylglycerol outcome. Curr Opin Clin Nutr Metab Care 7:145–149
  Article PubMed CAS Google Scholar
• Fujii A, Allen TJ, Nestel PJ (2007) A 1, 3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice. Atherosclerosis 193:55–61
  Article PubMed CAS Google Scholar
• Meguro S, Osaki N, Matsuo N, Tokimitsu I (2006) Effect of diacylglycerol on the development of impaired glucose tolerance in sucrose-fed rats. Lipids 41:347–355
  Article PubMed CAS Google Scholar
• Murase T, Aoki M, Wakisaka T, Hase T, Tokimitsu I (2002) Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism. J Lipid Res 43:1312–1319
  PubMed CAS Google Scholar
• Yanai H, Tomono Y, Ito K, Furutani N, Yoshida H, Tada N (2007) Diacylglycerol oil for the metabolic syndrome. Nutr J 6:43–45
  Article PubMed CAS Google Scholar
• Holland WL, Summers SA (2008) Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 29:381–402
  Article PubMed CAS Google Scholar
• Kitatani K, Idkowiak-Baldys J, Hannun YA (2008) The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20:1010–1018
  Article PubMed CAS Google Scholar
• Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, Summers SA (2003) A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278:10297–10303
  Article PubMed CAS Google Scholar
• Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42–72
  Article PubMed CAS Google Scholar
• Gorska M, Dobrzyn A, Zendzian-Piotrowska M, Gorski J (2004) Effect of streptozotocin-diabetes on the functioning of the sphingomyelin-signalling pathway in skeletal muscles of the rat. Horm Metab Res 36:14–21
  Article PubMed CAS Google Scholar
• Adams JM 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25–31
  Article PubMed CAS Google Scholar
• Powell DJ, Hajduch E, Kular G, Hundal HS (2003) Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol 23:7794–7808
  Article PubMed CAS Google Scholar
• Summers SA, Garza LA, Zhou H, Birnbaum MJ (1998) Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18:5457–5464
  PubMed CAS Google Scholar
• Resjo S, Goransson O, Harndahl L, Zolnierowicz S, Manganiello V, Degerman E (2002) Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cell Signal 14:231–238
  Article PubMed CAS Google Scholar
• Di Marzo V, Petrosino S (2007) Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 18:129–140
  Article PubMed CAS Google Scholar
• González S, Cascio MG, Fernández-Ruiz J, Fezza F, Di Marzo V, Ramos JA (2002) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954:73–81
  Article PubMed Google Scholar
• Zhang M, Martin BR, PhD AdlerMW, Razdan RK, Ganea D, Tuma RF (2008) Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury. Neuroscience 152:753–760
  Article PubMed CAS Google Scholar
• Zhao Y, Yuan Z, Liu Y, Xue J, Tian Y, Liu W, Zhang W, Shen Y, Xu W, Liang X, Chen T (2010) Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules. J Cardiovasc Pharmacol 55:292–298
  Article PubMed CAS Google Scholar
• Di Marzo V (2008) The endocannabinoid system in obesity and type 2 diabetes. Diabetologia 51:1356–1367
  Article PubMed CAS Google Scholar
• Nogueiras R, Rohner-Jeanrenaud F, Woods SC, Tschöp MH (2008) The endocannabinoid system and the control of glucose homeostasis. J Neuroendocrinol 20(Suppl 1):147–151
  Article PubMed CAS Google Scholar
• Micale V, Mazzola C, Drago F (2007) Endocannabinoids and neurodegenerative diseases. Pharmacol Res 56(5):382–392
  Article PubMed CAS Google Scholar
• Mechoulam R, Spatz M, Shohami E (2002) Endocannabinoids and neuroprotection. Sci STKE 129:RE5
  Google Scholar
• Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 80:448–456
  Article PubMed CAS Google Scholar
• Fernández-Ruiz J (2009) The endocannabinoid system as a target for the treatment of motor dysfunction. Br J Pharmacol 156:1029–1040
  Article PubMed CAS Google Scholar
• Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutiérrez SO, van der Stelt M, López-Rodriguez ML, Casanova E, Schütz G, Zieglgänsberger W, Di Marzo V, Behl C, Lutz B (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302:84–88
  Article PubMed CAS Google Scholar
• Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95:437–445
  Article PubMed CAS Google Scholar
• Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128
  Article PubMed CAS Google Scholar
• Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 68:255–264
  Article PubMed CAS Google Scholar
• Keller JN, Mattson MP (1998) Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 9:105–116
  Article PubMed CAS Google Scholar
• Kadoya A, Miyake H, Ohyashiki T (2003) Contribution of lipid dynamics on the inhibition of bovine brain synaptosomal Na+-K+-ATPase activity induced by 4-hydroxy-2-nonenal. Biol Pharm Bull 26:787–793
  Article PubMed CAS Google Scholar
• McConkey DJ (1996) The role of calcium in the regulation of apoptosis. Scanning Microsc 10:777–793
  PubMed CAS Google Scholar
• Xu B, Chen S, Luo Y, Chen Z, Liu L, Zhou H, Chen W, Shen T, Han X, Chen L, Huang S (2011) Calcium signaling is involved in cadmium-induced neuronal apoptosis via induction of reactive oxygen species and activation of MAPK/mTOR network PLoS One. 6:e19052
• Keller JN, Mark RJ, Bruce AJ, Blanc E, Rothstein JD, Uchida K, Wäg G, Mattson MP (1997) 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80:685–696
  Article PubMed CAS Google Scholar
• Vincent HK, Powers SK, Dirks AJ, Scarpace PJ (2001) Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord 25:378–388
  Article PubMed CAS Google Scholar
• Russell AP, Gastaldi G, Bobbioni-Harsch E, Arboit P, Gobelet C, Dériaz O, Golay A, Witztum JL, Giacobino JP (2003) Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett 551:104–106
  Article PubMed CAS Google Scholar
• Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD, Pearson M, Nassar M, Telljohann R, Maudsley S, Carlson O, John S, Laub DR, Mattson MP (2007) Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 42:665–674
  Article PubMed CAS Google Scholar
• Grimsrud PA, Picklo MJ Sr, Griffin TJ, Bernlohr DA (2007) Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics 6:624–637
  Article PubMed CAS Google Scholar
• Zarrouki B, Soares AF, Guichardant M, Lagarde M, Géloën A (2007) The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett 581:2394–2400
  Article PubMed CAS Google Scholar
• Mattson MP (2009) Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 44:625–633
  Article PubMed CAS Google Scholar
• Singh SP, Niemczyk M, Saini D, Awasthi YC, Zimniak L, Zimniak P (2008) Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. Biochemistry 47:3900–3911
  Article PubMed CAS Google Scholar
• Devaraj S, Wang-Polagruto J, Polagruto J, Keen CL, Jialal I (2008) High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism 57:867–870
  Article PubMed CAS Google Scholar
• Murakami H, Tamasawa N, Matsui J, Yamato K, JingZhi G, Suda T (2001) Plasma levels of soluble vascular adhesion molecule-1 and cholesterol oxidation product in type 2 diabetic patients with nephropathy. J Atheroscler Thromb 8:21–24
  PubMed CAS Google Scholar
• Krook A (2006) Can the liver X receptor work its magic in skeletal muscle too? Diabetologia 49:819–821
  Article PubMed CAS Google Scholar
• Knopp RH, Paramsothy P (2006) Oxidized LDL and abdominal obesity: a key to understanding the metabolic syndrome. Am J Clin Nutr 83:1–2
  PubMed CAS Google Scholar
• Ivanova PT, Milne SB, Forrester JS, Brown HA (2004) LIPID arrays: new tools in the understanding of membrane dynamics and lipid signaling. Mol Interv 4:86–96
  Article PubMed CAS Google Scholar
• Prineas RJ, Folsom AR, Kaye SA (1993) Central adiposity and increased risk of coronary artery disease mortality in older women. Ann Epidemiol 3:35–41
  Article PubMed CAS Google Scholar
• Kip KE, Morroguin OC, Kelley DE, Johnson BP, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE (2004) Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) study. Circulation 109:706–713
  Article PubMed Google Scholar
• Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT (2007) Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 194:214–221
  Article PubMed CAS Google Scholar
• Gazdzinski S, Kornak J, Weiner MW, Meyerhoff DJ (2008) Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol 63:652–657
  Article PubMed Google Scholar
• Lusis AJ, Attie AD, Reue K (2008) Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet 9:819–830
  Article PubMed CAS Google Scholar
• Kawamoto R, Tomita H, Oka Y, Kodama A (2005) Metabolic syndrome as a predictor of ischemic stroke in elderly persons. Intern Med 44:922–927
  Article PubMed Google Scholar
• Scott CL (2003) Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Cardiol 92:35i–42i
  Article PubMed Google Scholar
• McNeill A, Rosamond W, Girman C, Golden S, Schmidt MI, East H, Ballantyne C, Heiss G (2005) The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 28:385–390
  Article PubMed Google Scholar
• Wannamethee SG, Shaper AG, Lennon L, Morris RW (2005) Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644–2650
  Article PubMed Google Scholar
• Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, Wright C, Giardina EG, DiTullio MR, Homma S, Paik MC (2008) Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 39:30–35
  Article PubMed Google Scholar
• Farooqui AA (2010) Neurochemical aspects of neurotraumatic and neurodegenerative diseases. Springer, New York
  Book Google Scholar
• Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, Ito T, Nakagawa A, Kigoshi T, Ishibashi T, Nishio M, Uchida K (2001) Increased basal levels of plasma nitric oxide in type 2 diabetic subjects: relationship to microvascular complications. J Diabetes Complications 15:135–143
  Article PubMed CAS Google Scholar
• Cosentino F, Rubattu S, Savoia C, Venturelli V, Pagannonne E, Volpe M (2001) Endothelial dysfunction and stroke. J Cardiovasc Pharmacol 38(Suppl 2):S75–S78
  Article PubMed CAS Google Scholar
• Nazir FS, Alem M, Small M, Connell JM, Lees KR, Walters MR, Cleland SJ (2006) Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with type 2 diabetes. Diabet Med 23:398–402
  Article PubMed CAS Google Scholar
• Aoki I, Shimoyama K, Aoki N, Homori M, Yanagisawa A, Nakahara K, Kawai Y, Kitamura SI, Ishikawa K (1996) Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes. J Am Coll Cardiol 27:560–566
  Article PubMed CAS Google Scholar
• Davi G, Gennaro F, Spatola A, Catalano I, Averna M, Montalto G, Amato S, Notarbartolo A (1992) Thrombin-antithrombin III complexes in type II diabetes mellitus. J Diabetes Complicat 6:7–11
  Article PubMed CAS Google Scholar
• Romano M, Guagnano MT, Pacini G, Vigneri S, Falco A, Marinopiccoli M, Manigrasso MR, Basili S, Davi G (2003) Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab 88:5321–5326
  Article PubMed CAS Google Scholar
• Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Chambless LE, Myerson M, Wu KK, Sharrett AR, Boerwinkle E (2005) Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 165:2479–2484
  Article PubMed CAS Google Scholar
• Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, Lindgarde F (2003) Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 52:442–447
  Article PubMed CAS Google Scholar
• Trovati M, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Piretto V, Cavalot F, Anfossi G (1995) Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients. Diabetes 44:1318–1322
  Article PubMed CAS Google Scholar
• Wagenknecht LE, D’Agostino R Jr, Savage PJ, O’Leary DH, Saad MF, Haffner SM (1997) Duration of diabetes and carotid wall thickness: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke 28:999–1005
  Article PubMed CAS Google Scholar
• Biessels GJ, Kappelle LJ (2005) Increased risk of Alzheimer’s disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33:1041–1044
  Article PubMed CAS Google Scholar
• Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63:1187–1192
  PubMed Google Scholar
• Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF, Greengard P, Xu H (2001) Stimulation of betaamyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21:2561–2570
  PubMed CAS Google Scholar
• Perez A, Morell L, Cresto JC, Castano EM (2000) Degradation of soluble amyloid beta-peptides 1–40, 1–42, and the Dutch variant 1–40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem Res 25:247–255
  Article PubMed CAS Google Scholar
• Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, Santoro G, Davit A, Danni O, Smith MA, Perry G, Tabaton M (2005) Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 92:628–636
  Article PubMed CAS Google Scholar
• Sun MK, Alkon DL (2006) Links between Alzheimer’s disease and diabetes. Drugs Today (Barc) 42:481–489
  Article CAS Google Scholar
• Grossman H (2003) Does diabetes protect or provoke Alzheimer’s disease? Insights into the pathobiology and future treatment of Alzheimer’s disease. CNS Spectr 8:815–823
  PubMed Google Scholar
• Craft S, Reger MA, Baker LD (2006) Insulin resistance in Alzheimer’s disease—a novel therapeutic target. Alzheimer’s disease and related disorders Annual 5. Taylor and Francis, London, pp 111–133
  Google Scholar
• Revill P, Moral M, Prous JR (2006) Impaired insulin signaling and the pathogenesis of Alzheimer’s disease. Drug Today 42:785–790
  Article CAS Google Scholar
• Whitmer RA (2007) Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 7:373–380
  Article PubMed CAS Google Scholar
• van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW (2010) Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 122:30–39
  Article PubMed CAS Google Scholar
• McIntyre RS, Park KY, Law CW, Sultan F, Adams A, Lourenco MT, Lo AK, Soczynska JK, Woldeyohannes H, Alsuwaidan M, Yoon J, Kennedy SH (2010) The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications. CNS Drugs 24:741–753
  Article PubMed Google Scholar
• Wurtman RJ (2005) Genes, stress, and depression. Metabolism 54(5 Suppl 1):16–19
  Article PubMed CAS Google Scholar
• Brummett BH, Boyle SH, Siegler IC, Kuhn CM, Ashley-Koch A, Jonassaint CR, Züchner S, Collins A, Williams RB (2008) Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behav Genet 38:34–43
  Article PubMed Google Scholar
• Leonard BE, Myint A (2009) The psychoneuroimmunology of depression. Hum Psychopharmacol 24:165–175
  PubMed CAS Google Scholar
• Anisman H (2009) Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 34:4–20
  PubMed Google Scholar
• Swaab DF, Bao AM, Lucassen PJ (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4:141–194
  Article PubMed CAS Google Scholar
• Chesik D, Wilczak N, De Keyser J (2008) IGF-1 regulates cAMP levels in astrocytes through a beta2-adrenergic receptor-dependant mechanism. Int J Med Sci 5:240–243
  Article PubMed CAS Google Scholar
• Robertson SD, Matthies HJ, Owens WA, Sathananthan V, Christianson NS, Kennedy JP, Lindsley CW, Daws LC, Galli A (2010) Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci 30:11305–11316
  Article PubMed CAS Google Scholar
• Frisardi V, Panza F, Farooqui AA (2011) Late-life depression and Alzheimer’s disease: the glutamatergic system inside of this mirror relationship. Brain Res Rev 67:344–355
  Article PubMed CAS Google Scholar
• Bardgett ME, McCarthy JJ, Stocker SD (2010) Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia. Hypertension 55:284–290
  Article PubMed CAS Google Scholar
• Biancardi VC, Campos RR, Stern JE (2010) Altered balance of gamma-aminobutyric acidergic and glutamatergic afferent inputs in rostral ventrolateral medulla-projecting neurons in the paraventricular nucleus of the hypothalamus of renovascular hypertensive rats. J Comp Neurol 518:567–585
  Article PubMed CAS Google Scholar
• Novgorodtseva TP, Karaman YK, Zhukova NV, Lobanova EG, Antonyuk MV, Kantur TA (2011) Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome. Lipids Health Dis 10:82
  Article PubMed CAS Google Scholar
• Henkel J, Gärtner D, Dorn C, Hellerbrand C, Schanze N, Elz SR, Püschel GP (2011) Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis. Lab Invest 91:1107–1117
  Article PubMed CAS Google Scholar
• McLarnon JG, Choi HB, Lue LF, Walker DG, Kim SU (2005) Perturbations in calcium-mediated signal transduction in microglia from Alzheimer’s disease patients. J Neurosci Res 81:426–435
  Article PubMed CAS Google Scholar
• Derbent A, Kargili A, Koca C, Gümüş Iİ, Sevgili S, Simavli S, Karakurt F, Turhan NÖ (2011) Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus. Gynecol Endocrinol 27:128–133
  Article PubMed CAS Google Scholar
• Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA (2007) Lipid mediators of insulin resistance. Nutr Rev 65:S39–S46
  Article PubMed Google Scholar
• Alkazemi D, Egeland G, Vaya J, Meltzer S, Kubow S (2008) Oxysterol as a marker of atherogenic dyslipidemia in adolescence. J Clin Endocrinol Metab 93:4282–4289
  Article PubMed CAS Google Scholar